Zusammenfassung
Die temporäre Unterbrechung des Kreislaufs in der unteren Körperhälfte mit Hilfe eines pneumatischen Gürtels schützte das Knochenmark des Beckens weitgehend vor der Wirkung hoher Dosen von Stickstofflost oder Chloriminlost, wenn diese in eine Armvene injiziert wurden. Bei 16 von 40 Kranken mit anaplastischen Plattenepithelearcinomen des Nasopharynx wurde eine über Monate anhaltende Tumorregression mit entsprechender Besserung des Allgemeinbefindes erzielt. Nach spätestens 8 Monaten trat jedoch ein Rezidiv auf. Die tolerierte Dosis wurde nicht durch die Wirkung auf das Knochenmark, sondern durch Zeichen der Schädigung des Zentralnervensystems begrenzt.
Summary
Temporary mid — torso occlusion by means of a pneumatic tourniquet protected the pelvic bone marrow against the effects of high doses of nitrogen mustard and chlorimine mustard, injected into an arm vein. In 16 out of 40 patients with anaplastic carcinoma of the postnasal space regression of the tumor and corresponding improvement of the performance status, lasting for several months, were observed. Recurrence became evident latest after 8 months. The tolerated dose was limited not by bone marrow depression but by other toxic effects, presumably on the central nervous system.
Literatur
Bierman, H. R., G. J. Marshall, K. H. Kelly andR. L. Byron jr.: Protective effects of leukapheresis in man against large dose antineoplastic chemotherapy. Blood17, 303–313 (1960).
Block, M., Ch. L. Spurr, L. O. Jacobson andT. R. Smith: Histopathologic effects of nitrogen mustard therapy upon normal and neoplastic hematopoietic tissues. Amer. J. clin. Path.18, 671–689 (1948).
Clifford, P.: Malignant disease of the nose, paranasal sinuses and postnasal space in East Africa. J. Laryng.75, 707–733 (1961).
Clifford, P., R. A. Clift andJ. K. Duff: Nitrogen mustard therapy combined with autologuos marrow infusion. Lancet1961 I, 687–690.
Clifford, P., H. F. Oettgen, J. L. Beecher, F. P. Brown, J. R. Harries andW. E. Lawes: Nitrogen mustard therapy with aortic occlusion in nasopharyngeal carcinoma. Brit. med. J.1963 I, 1256.
Conrad, M. E., andW. H. Crosby: Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets. Blood16, 1089–1103 (1960).
Duff, J. K., J. Dennis, R. A. Clift, P. Clifford andH. F. Oettgen: High-dose nitrogen mustard therapy with intermittent aortic occlusion. Brit. med. J.1961 II 1523–1528.
Harries, J. R., F. P. Brown, J. L. Beecher andH. F. Oettgen: Haemodynamic effects of abdominal aorta during nitrogen mustard therapy. Brit. med. J. (1963) (im Druck).
Karnofsky, D. A.: Meaningful clinical classification of therapeutic responses to anticancer drugs. Clin. Pharmacol. Ther.2, 709–712 (1961).
McFarland, W., N. B. Grancille andW. Dameshek: Autologous bone marrow infusion as an adjunct in therapy of malignant diseases. Blood14, 503–521 (1959).
Miller, D. G., andW. Lawrence: Successful bone marrow protection by vascular occlusion following large doses of nitrogen mustard therapy. Proc. Amer. Ass. Cancer Res.3, 251 (1961).
Miller, D. G., W. Lawrence jr.,M. Kim, D. Dorencamp andH. T. Randall: Midtorso occlusion for regional cancer chemotherapy. Cancer Chemother. Rep.18, 43–47 (1962).
Spurr, C. L., L. O. Jacobson, T. R. Shmith andE. S. Guzman-Barron: The clinical application of methyl-bis-(β-chloroethyl)amine hydrochloride to the treatment of lymphoma and allied dyscrasias. In: Approaches to tumor chemotherapy, ed.F. R. Moulton. Lancaster, Pa.: The Science Press Printing Company, 1947.
Author information
Authors and Affiliations
Additional information
Die Untersuchungen wurden unterstützt durch die Alfred P. Sloan Foundation, die Charles F. Kettering Foundation, den Charles Merrill Trust und die American Cancer Society.
Rights and permissions
About this article
Cite this article
Oettgen, H.F., Clifford, P., Beecher, J.L. et al. Regionale Chemotherapie maligner Tumoren. Klin Wochenschr 42, 218–224 (1964). https://doi.org/10.1007/BF01487946
Issue Date:
DOI: https://doi.org/10.1007/BF01487946